Publications by authors named "Peter T Nower"

Claim this Profile
S
Synergistic Activity of Combined NS5A Inhibitors.
Donald R O'Boyle, Peter T Nower, Min Gao, Robert Fridell, Chunfu Wang

Antimicrob Agents Chemother· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activity.
Denis R St Laurent, Michael H Serrano-Wu, Makonen Belema, Min Ding, Hua Fang, Peter T Nower

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons.
Makonen Belema, Van N Nguyen, Jeffrey L Romine, Denis R St Laurent, Omar D Lopez, Peter T Nower

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 96-well based analysis of replicon elimination with the HCV NS5A replication complex inhibitor daclatasvir.
Donald R O'Boyle, Peter T Nower, Jin-Hua Sun, Robert Fridell, Chunfu Wang

J Virol Methods· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizations of HCV NS5A replication complex inhibitors.
Donald R O'Boyle Ii, Jin-Hua Sun, Peter T Nower, Julie A Lemm, Robert A Fridell

Virology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivatives.
Makonen Belema, Van N Nguyen, Denis R St Laurent, Omar D Lopez, Yuping Qiu, Peter T Nower

Bioorg Med Chem Lett· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologies.
Omar D Lopez, Van N Nguyen, Denis R St Laurent, Makonen Belema, Michael H Serrano-Wu, Peter T Nower

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV NS5A replication complex inhibitors. Part 2: investigation of stilbene prolinamides.
Denis R St Laurent, Makonen Belema, Min Gao, Jason Goodrich, Ramesh Kakarla, Peter T Nower

Bioorg Med Chem Lett· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of BMS-790052 on hepatitis C virus genotype 4 NS5A.
Chunfu Wang, Lingling Jia, Haichang Huang, Dike Qiu, Lourdes Valera, Peter T Nower

Antimicrob Agents Chemother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052.
Chunfu Wang, Haichang Huang, Lourdes Valera, Jin-Hua Sun, Donald R O'Boyle, Peter T Nower

Antimicrob Agents Chemother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization.
Dike Qiu, Julie A Lemm, Donald R O'Boyle, Jin-Hua Sun, Peter T Nower

J Gen Virol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent hepatitis C virus NS5A inhibitors with dimeric structures.
Julie A Lemm, John E Leet, Donald R O'Boyle, Jeffrey L Romine, Xiaohua Stella Huang, Peter T Nower

Antimicrob Agents Chemother· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes.
Jeffrey L Romine, Denis R St Laurent, John E Leet, Scott W Martin, Michael H Serrano-Wu, Peter T Nower

ACS Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of hepatitis C virus NS5A inhibitors.
Julie A Lemm, Donald O'Boyle, Mengping Liu, Peter T Nower, Richard Colonno

J Virol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.
Donald R O'Boyle, Peter T Nower, Julie A Lemm, Lourdes Valera, Jin-Hua Sun

Antimicrob Agents Chemother· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis